Danuglipron (PF-06882961) in Type 2 Diabetes: a Randomized, Placebo-Controlled, Multiple Ascending-Dose Phase 1 Trial
Nature Medicine（2021）
Key words
Drug development,Translational research,Biomedicine,general,Cancer Research,Metabolic Diseases,Infectious Diseases,Molecular Medicine,Neurosciences
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined